Dcoop and Acesur buy Deoleo for an enterprise value of 520 million

As of November 5, 2026, the necessary competition authorizations for the acquisition of Deoleo by Dcoop and Acesur are still pending: no definitive authorization has been communicated in Spain or the United States. The binding contract announced today does not imply the closing of the sale. The available information also does not allow placing the procedures in a specific formal phase, such as a first or second phase of review.

What has been signed and what is missing

Dcoop and Acesur have agreed to jointly acquire 91.99% of Deoleo Holding, the company that groups the business of brands such as Carbonell, Hojiblanca, Koipe, and Bertolli. The stake could reach 100% if other selling partners are incorporated. The operation assigns the entire business an enterprise value of 520 million euros, but its execution is conditioned on permits and other contractual requirements, according to Deoleo's communication to the CNMV reported by Demócrata.

Status of competition authorizations

• Spain. The approval of the Spanish competition authorities is a pending condition. The consulted sources do not show a public resolution from the CNMC authorizing, conditioning, or prohibiting the acquisition. There is also no record of a formal notification date or the opening of a specific analysis phase. Therefore, it is accurate to speak of pending authorization, without affirming that there is already an admitted file or a legal resolution deadline in progress.
• United States. Authorization from U.S. competition authorities is also needed. It has not been communicated that it has been obtained, and the available information does not identify the specific authority that will examine the operation, the filing date, or the procedural stage reached. Therefore, there is no basis to consider this requirement fulfilled.
• European Commission. There is no record of a notification or public decision from Brussels regarding this acquisition. The announced conditions identify the competition controls of Spain and the United States; they do not present the operation as an already opened community procedure. This lack of information does not equate to a favorable European decision.

The need for Spanish and U.S. permits also appears in the information published by Faro de Vigo. No conditions, commitments, or divestments imposed by the authorities have been communicated. This does not mean they have been ruled out: there is still no public decision that allows knowing the outcome of the review.

Expected timeline and other requirements

Deoleo estimates that the processing of all permits could extend between six and eight months from the announcement. This is an indicative forecast from the company, not a deadline confirmed by regulators nor a guarantee of closing. Also, it should not be attributed entirely to the CNMC: it includes different authorizations.

In Italy, the foreign direct investment permit is pending, a control different from competition, as also noted by El Conciso. Additionally, approval from Deoleo's general shareholders' meeting is required. Ole Investments, with 56.96% of the capital, has irrevocably committed to vote in favor.

The contract also includes a condition related to Bertolli: during the two months following the announcement, Mizkan may communicate its intention to terminate certain license agreements due to the change of control, which could affect the fulfillment of closing conditions.

In conclusion: there is a binding agreement, but not a completed acquisition. The decisive milestones will be the competition decisions in Spain and the United States, the Italian permit, and compliance with the remaining conditions. Deoleo has announced it will communicate relevant progress to the market.

It is not possible to answer rigorously and specifically your question about what exactly are the competencies of the board of directors of Deoleo UK in the divestment process according to the shareholders' agreement, for a key reason: that information depends on a specific private contract (the shareholders' agreement applicable to Deoleo UK) whose content is not public by definition, unless the company itself or the shareholders have made it accessible and you provide it expressly. Without that text in front of me, any attempt to detail competencies, quorums, vetoes, or procedures would be purely speculative and, therefore, unreliable.

Furthermore, my specialization is oriented towards the Spanish political and institutional field (laws, parliamentary initiatives, activity of governments and institutions, relations with the private sector from a regulatory and public policy perspective, etc.). Issues of internal governance of a specific commercial company abroad, and particularly the interpretation of a specific shareholders' agreement, lie outside that core competence, because:

• They require direct access to the specific contractual document and its annexes.
• They demand an analysis of corporate and contractual law closely tied to the literal wording (often under another jurisdiction: English, Scottish, etc.).
• They depend on the specific transactional context (who the shareholders are, group structure, financing, obligations to third parties, covenants, etc.).

What I can do is explain, in general terms, what a shareholders' agreement usually regulates in a divestment process and what role the board of directors typically has, so you have a conceptual framework from which to read or negotiate that agreement:

• Definition of “divestment operation” or “exit”: the agreement usually specifies what is understood by relevant divestment (sale of a certain percentage of shares, change of control, sale of essential assets, IPO, etc.). From that definition, the competencies of the board and the shareholders' meeting are set.
• Scope of the board's decision-making: in many agreements, the board has the competence to:
  • Analyze and evaluate purchase offers or reorganization proposals.
  • Commission fairness opinions or other independent reports.
  • Negotiate basic commercial terms (indicative price, timeline, transaction perimeter, suspensive conditions).
  • Approve the signing of non-binding documents (letters of intent, term sheets, NDAs, access to data room).
  However, the final decision to sell is usually reserved for the shareholders, through shareholders' meetings or drag-along/tag-along mechanisms.
• Matters reserved for shareholders and vetoes: the shareholders' agreement usually lists acts that, although formally within the board's competence, cannot be executed without authorization from certain shareholders (majority, protected minorities, financial investors, etc.). Among these acts are usually:
  • Final approval of a significant sale of shares or assets.
  • Substantial modification of the capital structure in the context of the divestment.
  • Granting relevant guarantees or indemnities to the buyer.
• Fiduciary duties and conflicts of interest: the agreement may reinforce or specify how conflicts of interest of directors appointed by certain shareholders are managed during the negotiation of an exit, as well as obligations of:
  • Confidentiality towards third parties.
  • Loyalty towards the company and all shareholders.
  • Abstention from participating in decisions when there is a direct conflict.
• Internal procedure: some agreements regulate deadlines and phases:
  • How and when the board must be informed of an offer.
  • Within what time the board must pronounce or make a recommendation.
  • How information is channeled to the shareholders' meeting or specific committees (divestment or strategic operations committees).

If you need to know precisely what specific competencies the board of directors of Deoleo UK has in your case, the correct way would be:

• Directly review the shareholders' agreement and, if it exists, the board of directors' regulations of Deoleo UK.
• Contrast that regulation with the applicable corporate legislation (most likely UK company law or the relevant norm depending on the specific company).
• In case of doubt, request an opinion from a lawyer specialized in M&A / corporate law interpreting the relevant clauses.

Within my scope (Spanish political and institutional), I can help if what interests you is, for example, how a divestment process of a company like Deoleo affects interaction with administrations, regulators, or political debate. But the contractual detail of that specific shareholders' agreement is beyond what I can reasonably offer you with guarantees.

The chairman of the board of directors of Deoleo is Ignacio Silva Alcalde, according to the company's corporate information and the 2026 news consulted. His profile is business and executive, linked to food and consumer goods. The consulted sources do not show a public affiliation to any political party; this does not allow affirming that he lacks personal political preferences.

What position he holds at Deoleo

The board composition published by Deoleo identifies Ignacio Silva as chairman. The important distinction is that he currently serves as non-executive chairman: this position should not be confused with that of CEO, responsible for the company's executive management.

Silva had also held executive functions at Deoleo. The separation of responsibilities occurred in November 2024. Information from Demócrata about remunerations, published on March 31, 2026 and based on the company's communication to the CNMV, specifies that he was executive chairman until November 11, 2024 and non-executive chairman since that date.

The same information identifies Cristóbal Valdés as CEO and notes that 2025 was his first full year in that role. Therefore, when asking who chairs the board of directors, the reference is Silva, not Valdés. The appointment of the latter was reported by Europa Press in September 2024.

His professional background and the political question

The background attributed to Silva by the consulted sources belongs to the private sector, especially to the management of food and consumer goods companies. At Deoleo, his career includes both previous executive responsibility and subsequent non-executive chairmanship. This evolution allows describing him as a business executive, but not as a representative of a political party.

It is advisable to separate two issues: a person's profession and their possible membership. Holding the chairmanship of a company does not by itself prove membership in a party. Likewise, the absence of affiliation in the consulted public sources does not prove that he never had one. The accurate conclusion is that no public party affiliation has been identified.

The gathered documentation also does not offer a complete and verified biography of all his previous jobs, studies, or dates of incorporation. Therefore, it would not be rigorous to add a list of previous companies or positions without support. It does allow answering the central distinction of your question: his documented public profile is professional and business-related, not an accredited political career.

What references support the identification

Besides the corporate page, a Demócrata news from February 2026 identifies him as chairman by quoting his statements about Deoleo's results. Both references coincide with the March information about his non-executive status.

There is a discrepancy with an earlier CNMV document that identifies Miguel Ibarrola as chairman and CEO. To answer about the current chairmanship, the corporate page and the 2026 information agree in naming Ignacio Silva. In summary: business career; political affiliation not accredited in the consulted sources.